Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II)

Bokun Cheng, Thirunavukkarasu Annamalai, Shayna Sandhaus, Priyanka Bansod, Yuk Ching Tse-Dinh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Type IA topoisomerase activities are essential for resolving DNA topological barriers via an enzyme-mediated transient single strand DNA break. Accumulation of topoisomerase DNA cleavage product can lead to cell death or genomic rearrangement. Many antibacterial and anticancer drugs act as topoisomerase poison inhibitors that form stabilized ternary complexes with the topoisomerase covalent intermediate, so it is desirable to identify such inhibitors for type IA topoisomerases. Here we report that organomercury compounds were identified during a fluorescence based screening of the NIH diversity set of small molecules for topoisomerase inhibitors that can increase the DNA cleavage product of Yersinia pestis topoisomerase I. Inhibition of relaxation activity and accumulation of DNA cleavage product were confirmed for these organomercury compounds in gel based assays of Escherichia coli topoisomerase I. Hg(II), but not As(III), could also target the cysteines that form the multiple Zn(II) binding tetra-cysteine motifs found in the C-terminal domains of these bacterial topoisomerase I for relaxation activity inhibition. Mycobacterium tuberculosis topoisomerase I activity is not sensitive to Hg(II) or the organomercury compounds due to the absence of the Zn(II) binding cysteines. It is significant that the type IA topoisomerases with Zn(II) binding domains can still cleave DNA when interfered by Hg(II) or organomercury compounds. The Zn(II) binding domains found in human Top3a and Top3β may be potential targets of toxic metals and organometallic complexes, with potential consequence on genomic stability and development.

Original languageEnglish (US)
Article numbere0120022
JournalPloS one
Volume10
Issue number3
DOIs
StatePublished - Mar 23 2015
Externally publishedYes

Fingerprint

Organomercury Compounds
organomercury compounds
DNA topoisomerase
Type I DNA Topoisomerase
Topoisomerase Inhibitors
DNA Cleavage
Cysteine
Poisons
DNA
cysteine
Yersinia pestis
Single-Stranded DNA Breaks
Genomic Instability
Coordination Complexes
genomics
Mycobacterium tuberculosis
antineoplastic agents
Organometallics
Cell death
Cell Death

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II). / Cheng, Bokun; Annamalai, Thirunavukkarasu; Sandhaus, Shayna; Bansod, Priyanka; Tse-Dinh, Yuk Ching.

In: PloS one, Vol. 10, No. 3, e0120022, 23.03.2015.

Research output: Contribution to journalArticle

Cheng, Bokun ; Annamalai, Thirunavukkarasu ; Sandhaus, Shayna ; Bansod, Priyanka ; Tse-Dinh, Yuk Ching. / Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II). In: PloS one. 2015 ; Vol. 10, No. 3.
@article{e42042ec910c4ea8bd4373718f01be8d,
title = "Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II)",
abstract = "Type IA topoisomerase activities are essential for resolving DNA topological barriers via an enzyme-mediated transient single strand DNA break. Accumulation of topoisomerase DNA cleavage product can lead to cell death or genomic rearrangement. Many antibacterial and anticancer drugs act as topoisomerase poison inhibitors that form stabilized ternary complexes with the topoisomerase covalent intermediate, so it is desirable to identify such inhibitors for type IA topoisomerases. Here we report that organomercury compounds were identified during a fluorescence based screening of the NIH diversity set of small molecules for topoisomerase inhibitors that can increase the DNA cleavage product of Yersinia pestis topoisomerase I. Inhibition of relaxation activity and accumulation of DNA cleavage product were confirmed for these organomercury compounds in gel based assays of Escherichia coli topoisomerase I. Hg(II), but not As(III), could also target the cysteines that form the multiple Zn(II) binding tetra-cysteine motifs found in the C-terminal domains of these bacterial topoisomerase I for relaxation activity inhibition. Mycobacterium tuberculosis topoisomerase I activity is not sensitive to Hg(II) or the organomercury compounds due to the absence of the Zn(II) binding cysteines. It is significant that the type IA topoisomerases with Zn(II) binding domains can still cleave DNA when interfered by Hg(II) or organomercury compounds. The Zn(II) binding domains found in human Top3a and Top3β may be potential targets of toxic metals and organometallic complexes, with potential consequence on genomic stability and development.",
author = "Bokun Cheng and Thirunavukkarasu Annamalai and Shayna Sandhaus and Priyanka Bansod and Tse-Dinh, {Yuk Ching}",
year = "2015",
month = "3",
day = "23",
doi = "10.1371/journal.pone.0120022",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II)

AU - Cheng, Bokun

AU - Annamalai, Thirunavukkarasu

AU - Sandhaus, Shayna

AU - Bansod, Priyanka

AU - Tse-Dinh, Yuk Ching

PY - 2015/3/23

Y1 - 2015/3/23

N2 - Type IA topoisomerase activities are essential for resolving DNA topological barriers via an enzyme-mediated transient single strand DNA break. Accumulation of topoisomerase DNA cleavage product can lead to cell death or genomic rearrangement. Many antibacterial and anticancer drugs act as topoisomerase poison inhibitors that form stabilized ternary complexes with the topoisomerase covalent intermediate, so it is desirable to identify such inhibitors for type IA topoisomerases. Here we report that organomercury compounds were identified during a fluorescence based screening of the NIH diversity set of small molecules for topoisomerase inhibitors that can increase the DNA cleavage product of Yersinia pestis topoisomerase I. Inhibition of relaxation activity and accumulation of DNA cleavage product were confirmed for these organomercury compounds in gel based assays of Escherichia coli topoisomerase I. Hg(II), but not As(III), could also target the cysteines that form the multiple Zn(II) binding tetra-cysteine motifs found in the C-terminal domains of these bacterial topoisomerase I for relaxation activity inhibition. Mycobacterium tuberculosis topoisomerase I activity is not sensitive to Hg(II) or the organomercury compounds due to the absence of the Zn(II) binding cysteines. It is significant that the type IA topoisomerases with Zn(II) binding domains can still cleave DNA when interfered by Hg(II) or organomercury compounds. The Zn(II) binding domains found in human Top3a and Top3β may be potential targets of toxic metals and organometallic complexes, with potential consequence on genomic stability and development.

AB - Type IA topoisomerase activities are essential for resolving DNA topological barriers via an enzyme-mediated transient single strand DNA break. Accumulation of topoisomerase DNA cleavage product can lead to cell death or genomic rearrangement. Many antibacterial and anticancer drugs act as topoisomerase poison inhibitors that form stabilized ternary complexes with the topoisomerase covalent intermediate, so it is desirable to identify such inhibitors for type IA topoisomerases. Here we report that organomercury compounds were identified during a fluorescence based screening of the NIH diversity set of small molecules for topoisomerase inhibitors that can increase the DNA cleavage product of Yersinia pestis topoisomerase I. Inhibition of relaxation activity and accumulation of DNA cleavage product were confirmed for these organomercury compounds in gel based assays of Escherichia coli topoisomerase I. Hg(II), but not As(III), could also target the cysteines that form the multiple Zn(II) binding tetra-cysteine motifs found in the C-terminal domains of these bacterial topoisomerase I for relaxation activity inhibition. Mycobacterium tuberculosis topoisomerase I activity is not sensitive to Hg(II) or the organomercury compounds due to the absence of the Zn(II) binding cysteines. It is significant that the type IA topoisomerases with Zn(II) binding domains can still cleave DNA when interfered by Hg(II) or organomercury compounds. The Zn(II) binding domains found in human Top3a and Top3β may be potential targets of toxic metals and organometallic complexes, with potential consequence on genomic stability and development.

UR - http://www.scopus.com/inward/record.url?scp=84925762305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925762305&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0120022

DO - 10.1371/journal.pone.0120022

M3 - Article

C2 - 25798600

AN - SCOPUS:84925762305

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0120022

ER -